Navigation Links
Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma
Date:6/8/2008

are deaths associated with an infusion reaction symptom complex have occurred within 24 hours of rituximab infusions. Yttrium-90 Zevalin administration results in severe and prolonged cytopenias in most patients. Severe cutaneous and mucocutaneous reactions have been reported. The most serious adverse reactions of the Zevalin therapeutic regimen were primarily hematologic, including neutropenia, thrombocytopenia, and anemia. Infusion-related toxicities were associated with pre-administration of rituximab. The risk of hematologic toxicity correlated with the degree of bone marrow involvement prior to Zevalin therapy. Myelodysplasia or acute myelogenous leukemia was observed in 2 percent of patients (8 to 34 months after treatment). Zevalin should only be used by health care professionals qualified by training and experience in the safe use of radionuclides.

Patients and healthcare professionals can visit http://www.zevalin.com for more information.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products. For additional information, please visit http://www.CellTherapeutics.com.

Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_news.htm

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties that could affect the development of Zevalin include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general and with Zevalin in particular including, without limitation, the potential f
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens
2. Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
3. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
4. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
5. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
6. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
7. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
8. New Study Shows Proprietary Canola Extract, Dermytol(TM), Produces Pronounced Decrease in Malignant Melanoma Tumor Volume
9. Fludarabine, Mitoxantrone and Zevalin(R) Produces 96% Complete Remission Rate in First-Line Treatment of Patients with Follicular Non-Hodgkins Lymphoma
10. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
11. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ... Advanced Bearing Technology with Vitamin E by celebrating a ... this month reported that, at 96 million cycles of ... Technology featuring Vitamin E grafted highly crosslinked polyethylene hip ... reduction of 95 percent, with no cracking, delamination or ...
(Date:3/26/2015)... -- Even the Score today marked this week,s 17 ... landmark approval of Viagra with the release of a ... the Agency to begin restoring gender equity in sexual ... most common sexual dysfunction. Currently, men have ... dysfunction – while women have zero biological treatment options ...
(Date:3/26/2015)... , March 26, 2015 ... and Drug Safety Software Market by Functionality (Adverse Event ... based (SAAS)), End-user (Pharma & Biotech Companies, CROs, ... MarketsandMarkets, the Pharmacovigilance and Drug Safety Software Market ... 6.5% during 2014-2019, and is expected to reach ...
Breaking Medicine Technology:Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 2Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 4Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 2Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 3Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 4
... July 27, 2011 Reportlinker.com announces that ... in its catalogue: India ... Till 2016 http://www.reportlinker.com/p0575381/India-Cardiac-Catheters-and-Guidewires---Market-Trends-Till-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment ... This market report provides vital ...
... 26, 2011 Symmetry Medical Inc. (NYSE: SMA ... orthopaedic device industry and other medical markets, announced today that ... period ending July 2, 2011 before the market opens on ... conference call at 8:00 a.m. ET on Thursday, August 4, ...
Cached Medicine Technology:India Cardiac Catheters and Guidewires - Market Trends Till 2016 2India Cardiac Catheters and Guidewires - Market Trends Till 2016 3Symmetry Medical to Report Second Quarter 2011 Financial Results on August 4, 2011 2
(Date:3/27/2015)... 2015 In light of two lawsuits ... U.S. District Court, District of Massachusetts; and case number ... of Pennsylvania), the San Diego personal injury lawyers of ... announcing that they are available to investigate potential ... were prescribed Zofran while pregnant and who gave birth ...
(Date:3/26/2015)... 26, 2015 Let’s not lose focus ... produce are today’s traffic magnets. Three out of 4 ... of their produce department, according to a Packaged Facts ... people are looking to add more fruits and vegetables ... Manager® Day is April 2. As featured in the ...
(Date:3/26/2015)... 2015 UC Davis will establish a ... origins of schizophrenia: A Silvio O. Conte Center for ... such centers in the United States. , The center ... the National Institutes of Mental Health, which will allow ... that an origin of schizophrenia may be dysregulation of ...
(Date:3/26/2015)... 26, 2015 Xarelto lawsuits ( ... with the issuance of new court documents in ... According to an Order dated March 24th, the ... Xarelto injury claims in the U.S. District Court, ... to file cases directly in the proceeding. (In ...
(Date:3/26/2015)... “The SWEET Act is an important step to invigorate the ... parents who are working to reduce sugar in their family ... public health, and we will continue to stand on the ... families,” said Dr. Jane Delgado President and CEO of the ... Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman Rosa L. DeLauro. ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2
... the illness and depression, anxiety disorders, researchers say , ... of people with Parkinson,s disease are at increased risk ... The risk is particularly high in the brothers, sisters, ... age 75, said a team from the Mayo Clinic ...
... of Native American tribes, public health and environmental ... in,the U.S. Court of Appeals for the District ... that evade legally required cuts in,mercury pollution from ... broad coalition called for the complete reversal of ...
... Los,Angeles Jewish Home today broke ground on the first ... a decade, the newest in,California and the fastest-selling CCRC ... years after the city,s first senior housing was created ... to the number of,elderly residing in the region. Fountainview ...
... MOINES, Iowa, Dec. 6 A group of physicians ... appealing to both Democratic and,Republican candidates for President to ... highest quality hospitals, including their own., The appeal ... that was,prompted by threatened action by Senator Max Baucus, ...
... of Frutels, the Vitamin ... Gummy for Acne, ... principal of new business development consultancy BANKS., has,agreed to join Frutels, LLC ... years of executive marketing experience in apparel,cosmetics, fragrance and fashion accessories to ...
... to enhance care for Philadelphia Latinos, PHILADELPHIA, Dec. ... providing a total of $925,000 in funding through 2010,to ... of its,Charitable Medical Care Grant Program. The Grant program, ... that provide,free or low-cost health care to more than ...
Cached Medicine News:Health News:Relatives of Parkinson's Patients at Higher Psychiatric Risk 2Health News:EPA Plan to Evade Required Cuts in Mercury Pollution Challenged in Court by States, Tribes, Health and Environmental Groups 2Health News:Construction Begins on Los Angeles' First New Continuing Care Retirement Community Facility in Over a Decade 2Health News:Iowa-S. Dakota Physicians Appeal to Presidential Candidates: 'Help Defend America's Safest and Highest Quality Hospitals' 2Health News:Iowa-S. Dakota Physicians Appeal to Presidential Candidates: 'Help Defend America's Safest and Highest Quality Hospitals' 3Health News:Iowa-S. Dakota Physicians Appeal to Presidential Candidates: 'Help Defend America's Safest and Highest Quality Hospitals' 4Health News:Marketing Powerhouse Wendy Banks Joins Frutels' Advisory Board 2Health News:Independence Blue Cross Gives Grants to Support Health Care for the Uninsured 2
Pefakit PiCT UFH Controls...
Pefakit PiCT LMWH Controls...
Pefakit PiCT LMWH Calibrators...
Pefakit TAFI Calibrators and Controls...
Medicine Products: